Broncho‐alveolar lavage in patients with acute respiratory distress syndrome due to COVID‐19

As data about microbiological testing and the cellular composition of the broncho‐alveolar lavage (BAL) fluid in patients ventilated due to coronavirus disease 2019 (COVID‐19) are lacking, this was investigated in a retrospective analysis (n = 58). Co‐infection with pathogens was detected in 31 pati...

Descripción completa

Detalles Bibliográficos
Autores principales: Cornelissen, Christian G., Bergs, Ingmar, Müller, Annegret G., Daher, Ayham, Kersten, Alexander, Balfanz, Paul, Lemmen, Sebastian, Marx, Gernot, Marx, Nikolaus, Dreher, Michael, Müller, Tobias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2021
Materias:
Brief Communications
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8447080/
https://www.ncbi.nlm.nih.gov/pubmed/34155764
http://dx.doi.org/10.1111/imj.15363
Descripción
Sumario:As data about microbiological testing and the cellular composition of the broncho‐alveolar lavage (BAL) fluid in patients ventilated due to coronavirus disease 2019 (COVID‐19) are lacking, this was investigated in a retrospective analysis (n = 58). Co‐infection with pathogens was detected in 31 patients, whereas the analysis of BAL cellularity showed an increased total cell count and an alveolitis dominated by neutrophils. None of the physicians performing bronchoscopies in COVID‐19 patients had serological evidence of severe acute respiratory syndrome coronavirus 2 infection.

Ejemplares similares